Participated · Equity · Jan 2023

NOCD delivers virtual-first, evidence-based OCD care through licensed therapists offering face-to-face video ERP sessions combined with self-help tools and personalized peer communities. Since launching in 2018, the company has expanded to all 50 states and internationally and now operates a network of 300+ OCD-specialized therapists. NOCD delivers more than 250,000 therapy sessions annually and reports an average 35% reduction in OCD symptom severity among members. The company conducted an 18-month retrospective study of over 3,500 therapy members—the largest OCD treatment study reported by the firm—to codify the efficacy of its care model. NOCD also reports coverage for more than 130 million commercial lives and emphasizes analytics and outcomes capabilities for payers. Going forward, NOCD plans to use new funding to expand its therapist network, enhance analytics and outcomes offerings for payers, and run public-awareness efforts with partners such as Howie Mandel to redefine perception of OCD. NOCD operates a telehealth platform focused exclusively on OCD treatment and has established the “Community‑Driven Therapy” category. Its core product pairs a nationwide network of licensed, ERP‑specialty therapists with always‑on peer groups, self‑help tools, and face‑to‑face telehealth sessions. The company delivers more than 12,000 live telehealth visits per month and reports outcomes showing a 40% improvement in patient health within as few as 90 days, after over 18 consecutive months of rapid growth. NOCD has partnered with leading health insurers so that more than a third of Americans have access to NOCD therapy as a covered benefit. The company is broadening clinical training to cover Hoarding Disorder, body‑focused repetitive behaviors (BFRBs), and common comorbid anxiety and mood disorders. NOCD is launching virtual partial hospitalization (PHP), intensive outpatient (IOP), and psychiatric treatment services and is expanding internationally to reach patients earlier and offer more long‑term services. NOCD operates an online therapy app focused on identifying and treating obsessive-compulsive disorder. The company says COVID-19 was a catalyst for product growth and an increase in therapy sessions. NOCD announced a $12 million Series A round to scale its operations. The funding will be used primarily to expand its provider network to all 50 states to reach the more than 8 million people in the U.S. with OCD. The company also plans to invest in technology and data science to ensure effective, convenient OCD therapy regardless of patient location. Investors in the round include Health Enterprise Partners, Hyde Park Angels, and previous backers 7Wire Ventures and Chicago Ventures. NOCD is a Chicago-based digital behavioral health company that identifies and manages people with obsessive-compulsive disorder (OCD). Led by CEO and founder Stephen Smith, NOCD operates a provider network designed to bring effective treatment to people with OCD. Via its app, members receive video-based diagnostic assessments and therapy with a specially trained clinician. The company raised $4M in a Series A financing to support growth. The round was led by Chicago Ventures with participation from 7Wire Ventures, Meridian Street Capital and Hyde Park Angels. NOCD intends to use the funds for nationwide expansion of its provider network. nOCD provides a treatment application for individuals with obsessive-compulsive disorder that collects 54 metrics to help researchers and clinicians use data to improve OCD treatment and connect with patients. The app helps users find mental health treatment and access clinical trials, and it analyzes anonymized data to understand the efficacy and adherence rates of interventions. It also enables distribution of interventions to patients more easily. Led by founder and CEO Stephen Smith, the Chicago, IL-based company raised $1M in funding. The company intends to use the funds to expand globally.

Led · Series B · May 2022

PatientIQ provides a cloud-based, EHR-integrated platform that systemically collects patient-reported outcomes and applies a proprietary analytics engine to generate actionable clinical and operational insights. The platform enables benchmarking, registries, collaboration among clinicians, and real-world evidence work without increasing administrative burden. PatientIQ plans to leverage new capital to further enhance its outcomes platform and accelerate expansion in the provider and real-world evidence markets. The company recently hired John Gerhardt as Chief Technology Officer and announced plans to double its headcount by the end of 2022 to meet rising demand. Operationally, PatientIQ has expanded its customer base from 29 healthcare organizations to more than 200 in two years, collecting outcomes from over 1.4 million patients and nearly 6 million outcome records. These metrics underpin its positioning as a scale provider of outcomes-data intelligence for clinical care and research.

Participated · Equity · Mar 2022

Led by CEO Leah Sparks, Wildflower Health builds digital and value-based care solutions for obstetric providers and payers. Its platform helps providers evaluate and design value-based care (VBC) models, install digital health and point-of-care decision-support tools, and adapt workflows to VBC requirements. The company continuously processes clinical and financial data to surface real-time clinical metrics and to manage payments, reconciliations, and outcomes measurement. Its proprietary maternity bundle spans prenatal to postnatal care and accounts for the total cost of pregnancy for both mother and baby. Wildflower plans to use new funding to strengthen its internal team and to prepare for nationwide expansion of that maternity bundle. Providence has increased its financial commitment and expanded a contract to install Wildflower’s solution across Southern California. Wildflower Health is a San Francisco-based mobile health software company that connects families to health resources on their smartphones. Its tools promote healthy pregnancies, track family health, and support the growth of each family member based on individual health needs over time. The company launched its Family Health platform, an integrated application to manage pregnancy and family health. Over the past year it tripled its recurring license revenue and expanded its user base by more than 10x. Led by founder and CEO Leah Sparks, Wildflower plans to use new funding to continue organizational growth and expand its Family Health platform. Wildflower Health builds Due Date Plus, a mobile maternity program that functions as a patient-navigation tool configurable by health plans to show coverage details and in‑network providers. The app is HIPAA‑compliant and is used by payers including Aetna, LifeMap and state Medicaid programs such as Wyoming’s. The company plans to broaden its product portfolio into pediatrics and family health and will launch a Spanish version of Due Date Plus in the coming months. Wildflower also agreed to a strategic partnership with Everyday Health, operator of the What to Expect franchise that reaches about 75% of pregnant women in the U.S. The new funding will support strategic expansion and ongoing product development. Wildflower Health offers Due Date Plus, a mobile maternity program available on iOS and Android that uses self-reported data to identify high-risk pregnancies and drive interventions. The app delivers customized tools and content and refers users to care management programs. The company plans to expand its mobile health offering to health plans, self-insured employers and Medicaid clients using the new funding. Wildflower was founded in 2012 by CEO Leah Sparks and Kathy Bellevin. Prior to this round the company secured seed funding in late 2012 through Rock Health.

Led · Series A · Jul 2021

Kno2 provides a platform and patented API technology that enables interoperability at scale, serving as a large network aggregator for healthcare information exchange. Its technology connects across every major national network, regional networks such as HIEs, cloud fax, proprietary platforms that drive workflows, and expanding EHR integrations. The company focuses on securely connecting all participants across the care continuum, both human and technological. Kno2 is led by CEO Jon Elwell and is based in Boise, ID and Scottsdale, AZ. The company intends to use new funding to continue developing its platform and to expand its reach into underserved markets such as small to medium physician offices, post-acute and behavioral health providers, and community services. Financial details in the article note a recent Series A raise of $15M.

Participated · Equity · Apr 2019

AllyAlign Health is a Medicare Advantage insurance company focused on serving residents of senior housing. The company is working to establish an integrated healthcare ecosystem within senior living communities to improve outcomes and the care experience for residents, community staff, physicians, and other caregivers. Its model centers on combining insurance and onsite care coordination in the senior housing setting. AllyAlign recently announced a new investment led by New Enterprise Associates. Participating investors include Oak HC/FT, Town Hall Ventures, and existing backers Heritage Group and Ziegler. The company is based in Richmond, VA. AllyAlign Health builds and administers Medicare Advantage special needs plans (I-SNPs, C-SNPs, D-SNPs) tailored to long-term care providers. Its proprietary technology platform streamlines and coordinates care across transitions and enables provider-sponsored managed care models. AAH assumes and manages full risk for aging patient populations while supplying infrastructure, clinical protocols and administrative services to make provider partners profitable under value-based care. The company says it launched its first health plan in 2016 and today manages plans in 17 states with more than 10,000 members. This financing will support expansion into assisted living, memory care and independent living facilities and bolster Medicare Advantage patient-centered care models. Total capital raised now exceeds $41 million. AllyAlign Health provides care management services that connect facilities and providers through care teams and technology to coordinate care for patients with chronic and complex medical conditions. The company uses a care management platform with mobile and web access to enable real-time, cross-boundary collaborative care and links patients to care teams and critical care-plan information. AllyAlign engages payers in quality-based contracts that reward alternative care delivery models for medically complex patients. Its goals are to improve patient outcomes, decrease costs, and improve the profitability of long-term care providers. The company aims to help the long-term care community become proactive with managed care payers and create new revenue streams needed for population health management. Will Saunders formed AllyAlign in 2013; the company emphasizes adapting long-term care providers to a changing managed care environment.